News and Events
March 2018
STRATEGIC INTERNATIONAL AGREEMENT
Cabinet Carrel advised VECT-HORUS S.A.S (Marseille, France) in the negotiation of a strategic collaboration and license agreement with Ono Pharmaceutical Co., Ltd. (Osaka, Japan).
February 2018
STRATEGIC fundraising
Cabinet Carrel and BG2V advised Anagenesis Biotechnologies in its second fundraising. A new year, a new step.
27 February 2018
STRATEGIC LICENSE AGREEMENT
Cabinet Carrel advises Domain Therapeutics in the negotiation of a Strategic License Agreement with Bristol-Myers Squibb under the G protein-coupled
receptor bioSens-All technology.
18 may 2017
STRATEGIC RESEARCH AGREEMENT
Cabinet Carrel advises Anagenesis in the negotiation of a Strategic Research Agreement with Boehringer Ingelheim to discover drugs for chronic muscle
diseases
2 may 2017
Le Cabinet Carrel participe à la matinale de France Biotech "Essais cliniques: les nouveaux cadres à connaître".
Réalisée par les membres du Carre des Juristes de France Biotech, cette présentation synthétisera les récentes évolutions juridiques et règlementaires de la recherche clinique en France.
1 décembre 2016
Alexandra Carrel anime une table ronde au Congrès BIOFIT 2016 à Lille sur le thème "Are Universities a short-term or long term partner for spin-offs".
